The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
M O HolmströmM D HjortsøS M AhmadÖ MetE MartinenaiteC RileyPer Thor StratenI M SvaneH C HasselbalchM H AndersenPublished in: Leukemia (2016)
Keyphrases